Cathie Wood’s ARK Invest Buys Over 420,000 Shares of UiPath
A couple of Cathie Wood's ARK Invest funds bought over 420,000 shares of UiPath on July 12.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A couple of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made huge purchases on Monday. Altogether, these funds bought over 420,000 shares of UiPath Inc. (NYSE: PATH | PATH Price Prediction), as the price of these ETFs dropped around 1% on Monday. Note that the funds are still up handily in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 149,800 shares of UiPath and ARK Innovation ETF (NYSEARCA: ARKK) bought 273,476 shares. At Monday’s closing price, this would have valued these purchases at roughly $28.1 million. Even though this is a small fraction of the total holdings, every little bit counts. ARKG is up about 60% and ARKK is up 57% in the past year.
Check out all of ARK Invest’s buys for Monday:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKF | FTCH | Farfetch | 75,608 |
| ARKG | VERV | Verve Therapeutics | 24,634 |
| ARKG | SGFY | Signify Health | 9,412 |
| ARKG | PATH | UiPath | 149,800 |
| ARKG | RXRX | Recursion Pharmaceuticals | 22,859 |
| ARKG | RPTX | Repare Therapeutics | 29,219 |
| ARKK | PATH | UiPath | 273,476 |
| ARKQ | KTOS | Kratos Defense & Security Solutions | 22,828 |
| ARKW | SPOT | Spotify Technology | 9,058 |
| ARKW | KVSB | Khosla Ventures Acquisition II | 110,200 |
| ARKW | DKNG | DraftKings | 137,133 |
| ARKW | COIN | Coinbase Global | 22,406 |
| ARKW | CND | Concord Acquisition | 3,800 |
| ARKW | ZM | Zoom Video Communications | 48,400 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Contact [email protected] for any questions or corrections.






